BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

NASDAQ:TECH • US09073M1045

57.92 USD
+0.05 (+0.09%)
At close: Feb 26, 2026
57.93 USD
+0.01 (+0.02%)
After Hours: 2/26/2026, 4:22:31 PM
Fundamental Rating

6

Overall TECH gets a fundamental rating of 6 out of 10. We evaluated TECH against 58 industry peers in the Life Sciences Tools & Services industry. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TECH is not valued too expensively and it also shows a decent growth rate. These ratings would make TECH suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • TECH had positive earnings in the past year.
  • TECH had a positive operating cash flow in the past year.
  • In the past 5 years TECH has always been profitable.
  • In the past 5 years TECH always reported a positive cash flow from operatings.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With a decent Return On Assets value of 3.17%, TECH is doing good in the industry, outperforming 74.14% of the companies in the same industry.
  • TECH's Return On Equity of 3.98% is fine compared to the rest of the industry. TECH outperforms 74.14% of its industry peers.
  • The Return On Invested Capital of TECH (9.52%) is better than 87.93% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TECH is below the industry average of 11.97%.
  • The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.17%
ROE 3.98%
ROIC 9.52%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • TECH has a better Profit Margin (6.58%) than 74.14% of its industry peers.
  • In the last couple of years the Profit Margin of TECH has declined.
  • TECH has a better Operating Margin (22.59%) than 93.10% of its industry peers.
  • TECH's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 66.60%, TECH belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
Industry RankSector Rank
OM 22.59%
PM (TTM) 6.58%
GM 66.6%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. Health

2.1 Basic Checks

  • TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • TECH has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TECH has more shares outstanding
  • Compared to 1 year ago, TECH has a worse debt to assets ratio.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • TECH has an Altman-Z score of 12.31. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
  • TECH has a better Altman-Z score (12.31) than 96.55% of its industry peers.
  • The Debt to FCF ratio of TECH is 1.17, which is an excellent value as it means it would take TECH, only 1.17 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of TECH (1.17) is better than 89.66% of its industry peers.
  • TECH has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • TECH has a Debt to Equity ratio of 0.13. This is in the better half of the industry: TECH outperforms 60.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.17
Altman-Z 12.31
ROIC/WACC0.88
WACC10.8%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 4.54 indicates that TECH has no problem at all paying its short term obligations.
  • The Current ratio of TECH (4.54) is better than 72.41% of its industry peers.
  • TECH has a Quick Ratio of 3.08. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 3.08, TECH perfoms like the industry average, outperforming 56.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 3.08
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 8.84% over the past year.
  • The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 1.64% in the past year.
  • TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.61% on average over the next years. This is quite good.
  • TECH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.10% yearly.
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 29.40, TECH can be considered very expensive at the moment.
  • 62.07% of the companies in the same industry are more expensive than TECH, based on the Price/Earnings ratio.
  • TECH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.05.
  • A Price/Forward Earnings ratio of 25.79 indicates a quite expensive valuation of TECH.
  • TECH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TECH is cheaper than 70.69% of the companies in the same industry.
  • TECH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.4
Fwd PE 25.79
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TECH is on the same level as its industry peers.
  • 63.79% of the companies in the same industry are more expensive than TECH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 40.63
EV/EBITDA 24.16
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)6.31
PEG (5Y)2.61
EPS Next 2Y7.87%
EPS Next 3Y10.61%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.54%, TECH is not a good candidate for dividend investing.
  • TECH's Dividend Yield is rather good when compared to the industry average which is at 0.10. TECH pays more dividend than 94.83% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, TECH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

  • The dividend of TECH has a limited annual growth rate of 0.11%.
  • TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of TECH decreased recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • TECH pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.38%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (2/26/2026, 4:22:31 PM)

After market: 57.93 +0.01 (+0.02%)

57.92

+0.05 (+0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners107.49%
Inst Owner Change4.03%
Ins Owners0.25%
Ins Owner Change1.58%
Market Cap9.06B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts81.74
Price Target71.44 (23.34%)
Short Float %6.31%
Short Ratio4.54
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)0%
PT rev (3m)5.24%
EPS NQ rev (1m)-3.7%
EPS NQ rev (3m)-4.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)-1.44%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 29.4
Fwd PE 25.79
P/S 7.45
P/FCF 40.63
P/OCF 36.35
P/B 4.51
P/tB 13.03
EV/EBITDA 24.16
EPS(TTM)1.97
EY3.4%
EPS(NY)2.25
Fwd EY3.88%
FCF(TTM)1.43
FCFY2.46%
OCF(TTM)1.59
OCFY2.75%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)6.31
PEG (5Y)2.61
Graham Number23.87
Profitability
Industry RankSector Rank
ROA 3.17%
ROE 3.98%
ROCE 11.53%
ROIC 9.52%
ROICexc 10.26%
ROICexgc 25.36%
OM 22.59%
PM (TTM) 6.58%
GM 66.6%
FCFM 18.35%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.17
Debt/EBITDA 0.69
Cap/Depr 25.35%
Cap/Sales 2.16%
Interest Coverage 15.32
Cash Conversion 65.89%
Profit Quality 278.92%
Current Ratio 4.54
Quick Ratio 3.08
Altman-Z 12.31
F-Score8
WACC10.8%
ROIC/WACC0.88
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year15.61%
EBIT Next 3Y13.34%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status of BIO-TECHNE CORP (TECH) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


What is the financial health of BIO-TECHNE CORP (TECH) stock?

The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.


Is the dividend of BIO-TECHNE CORP sustainable?

The dividend rating of BIO-TECHNE CORP (TECH) is 4 / 10 and the dividend payout ratio is 62.38%.